These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 5015373)

  • 1. The heterogeneity of the anticoagulant response to heparin.
    Estes JW
    J Clin Pathol; 1972 Jan; 25(1):45-8. PubMed ID: 5015373
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phosphatidylethanolamine and phosphatidylserine synergistically promote heparin's anticoagulant effect.
    van den Besselaar AM
    Blood Coagul Fibrinolysis; 1995 May; 6(3):239-44. PubMed ID: 7654938
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Laboratory observations and clinical implications of monitoring the effect of heparin by bioassay.
    Goodman TL; Todd ME; Goldsmith EI
    Surg Gynecol Obstet; 1976 May; 142(5):673-85. PubMed ID: 1265607
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Laboratory monitoring of heparin and the combination of heparin and the platelet glycoprotein IIb/IIIa receptor antibody fragment abciximab (c7E3) in patients undergoing percutaneous transluminal coronary angioplasty (PTCA).
    Zahn R; Haubelt H; Bechtloff S; Schneider S; Frilling B; Rustige J; Marsalek P; Seidl K; Senges J; Hellstern P
    Herz; 2003 Aug; 28(5):445-52. PubMed ID: 12928744
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activated coagulation time test: a convenient monitor of heparinization for dogs used in cardiovascular research.
    Wilkerson RD; Conran PB; Greene SL
    Lab Anim Sci; 1984 Feb; 34(1):62-5. PubMed ID: 6716959
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemorheological studies of the effect of heparin on the course of coagulation.
    Overholser KA; Baysinger CB; Harris TR; Deveau T
    Thromb Haemost; 1976 Apr; 35(2):447-59. PubMed ID: 989642
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low-dose heparin in gynecologic surgery: effect on blood coagulation tests.
    Levesque G; Samama M; Kher A; Barbier P; Horellou MH; Conard J
    Haemostasis; 1981; 10(2):97-103. PubMed ID: 7461507
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A new route of heparin administration--the lung.
    Kavanagh LW; Jaques LB
    Arzneimittelforschung; 1976; 26(3):389-92. PubMed ID: 989334
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anticoagulant effect of unfractionated heparin in antithrombin-depleted plasma in vitro.
    Krulder JW; Strebus AF; Meinders AE; Briët E
    Haemostasis; 1996; 26(2):85-9. PubMed ID: 9119287
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monitoring heparin therapy with the activated partial thromboplastin time.
    Stuart RK; Michel A
    Can Med Assoc J; 1971 Mar; 104(5):385-8. PubMed ID: 5557913
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Statistical correlation and heparin sensitivity of activated partial thromboplastin time, whole blood coagulation time, and an automated coagulation time.
    Schriever HG; Epstein SE; Mintz MD
    Am J Clin Pathol; 1973 Sep; 60(3):323-9. PubMed ID: 4728138
    [No Abstract]   [Full Text] [Related]  

  • 12. The biologic half-life of heparin.
    McAvoy TJ
    Clin Pharmacol Ther; 1979 Mar; 25(3):372-9. PubMed ID: 761447
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intrapulmonary heparin. A new procedure for anticoagulant therapy.
    Jaques LB; Mahadoo J; Kavanagh LW
    Lancet; 1976 Nov; 2(7996):1157-61. PubMed ID: 62993
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Influence of bigumal on the blood coagulation system and on the anticoagulant effect of heparin].
    kremneva VF; Ushkalova EA; Shcheglova NV
    Farmakol Toksikol; 1986; 49(6):43-5. PubMed ID: 3817142
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heparin dosing and monitoring for cardiopulmonary bypass. A comparison of techniques with measurement of subclinical plasma coagulation.
    Gravlee GP; Haddon WS; Rothberger HK; Mills SA; Rogers AT; Bean VE; Buss DH; Prough DS; Cordell AR
    J Thorac Cardiovasc Surg; 1990 Mar; 99(3):518-27. PubMed ID: 2308370
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of eosinophilia on the heterogeneity of the anticoagulant response to heparin in haemodialysis patients.
    Santoro A; Zucchelli P; Trombetti E; Degli Esposti E; Sturani A; Zuccalà A; Chiarini C; Casadei-Maldini M; Mazzuca A
    Proc Eur Dial Transplant Assoc Eur Ren Assoc; 1985; 21():143-9. PubMed ID: 3991493
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heparin neutralising activity of whole blood in patients undergoing vascular surgery.
    Harbourne T; Nicolaides AN; Golcman L; Shiffrin E
    J Cardiovasc Surg (Torino); 1987; 28(1):22-5. PubMed ID: 3805107
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of heparin in nonionic contrast media on blood coagulation and its dose response curve.
    Hwang MH; Piao ZE; Sheu SH
    Cathet Cardiovasc Diagn; 1990 Dec; 21(4):275-7. PubMed ID: 2276203
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heparin therapy.
    Raich PC; Hahn MF; Korst DR
    Am Fam Physician; 1974 Sep; 10(3):163-8. PubMed ID: 4413661
    [No Abstract]   [Full Text] [Related]  

  • 20. Heparin resistance during cardiopulmonary bypass. The role of heparin pretreatment.
    Esposito RA; Culliford AT; Colvin SB; Thomas SJ; Lackner H; Spencer FC
    J Thorac Cardiovasc Surg; 1983 Mar; 85(3):346-53. PubMed ID: 6827843
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.